Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
Southern Sierra Miwuk Nation regains ancestral lands near Yosemite in major c...
BY THE OPTIMIST DAILY EDITORIAL TEAM Nearly 900 acres of ancestral territory have been officially returned to the Southern Sierra Miwuk Nation, marking a ...
Read More8 fermented foods that your gut will love (and that taste great, too!)
BY THE OPTIMIST DAILY EDITORIAL TEAM Fermented foods have been a dietary staple in many cultures for centuries, but in the U.S., they’re only ...
Read MoreBreaking the silence: empowering menopausal women in the workplace
Addressing menopause in the workplace is long overdue in today's fast-changing work scene, where many are extending their careers into their 60s. According to ...
Read MoreInsect migration: the hidden superhighway of the Pyrenees
Insects, while frequently disregarded, are critical to the planet's ecosystems. They make up about 90 percent of all animal species and play important functions ...
Read More
